Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
0.3170
+0.0074 (2.39%)
Apr 1, 2025, 10:34 AM EDT - Market open
Co-Diagnostics Employees
Co-Diagnostics had 155 employees as of December 31, 2023. The number of employees increased by 10 or 6.90% compared to the previous year.
Employees
155
Change (1Y)
10
Growth (1Y)
6.90%
Revenue / Employee
$25,259
Profits / Employee
-$242,832
Market Cap
10.64M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CODX News
- 4 days ago - Co-Diagnostics, Inc. (CODX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results - PRNewsWire
- 19 days ago - Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast - PRNewsWire
- 4 weeks ago - Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025 - PRNewsWire
- 5 weeks ago - Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version - Benzinga
- 5 weeks ago - Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance - PRNewsWire
- 3 months ago - Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025 - PRNewsWire
- 4 months ago - Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility - PRNewsWire